{
    "2018-10-21": [
        [
            {
                "time": "2018-01-02",
                "original_text": "ACR 2018: Lilly Shares Updated Safety Analysis of OLUMIANTÂ® (baricitinib) in Patients with Moderately-to-Severely Active Rheumatoid Arthritis",
                "features": {
                    "keywords": [
                        "OLUMIANT",
                        "baricitinib",
                        "safety analysis",
                        "rheumatoid arthritis"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Lilly And Incyte Update Safety Analysis Of OLUMIANT",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Incyte",
                        "OLUMIANT",
                        "safety analysis"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Better Buy: Biogen Inc. vs. Amgen Inc.",
                "features": {
                    "keywords": [
                        "Biogen",
                        "Amgen",
                        "better buy"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology",
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}